Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PRE Prenetics Global Limited
- Stocks
- Healthcare
- NASDAQ: PRE
Price (delayed)
$7.01
Market cap
$91.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.71
Enterprise value
$44.54M
Highlights
Prenetics Global Limited's gross profit has surged by 74% YoY and by 9% QoQ
PRE's revenue is up by 41% YoY and by 20% from the previous quarter
The debt has surged by 144% year-on-year but it has declined by 11% since the previous quarter
The quick ratio has surged by 90% since the previous quarter but it has declined by 4.6% year-on-year
The equity has declined by 17% year-on-year and by 4.6% since the previous quarter
Key stats
What are the main financial stats of PRE
Market
Valuations
Earnings
Shares outstanding
12.98M
Market cap
$91.02M
Enterprise value
$44.54M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.5
Price to sales (P/S)
2.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.45
Revenue
$30.62M
Gross profit
$15.4M
Operating income
-$48.14M
Net income
-$46.3M
EBIT
-$54.18M
EBITDA
-$48.25M
Free cash flow
-$29.9M
Per share
Balance sheet
Liquidity
EPS
-$3.71
EPS diluted
-$3.71
Free cash flow per share
-$2.45
Book value per share
$13.94
Revenue per share
$2.51
TBVPS
$13.47
Total assets
$213.58M
Total liabilities
$42.23M
Debt
$5.77M
Equity
$170.39M
Working capital
$49.6M
Debt to equity
0.03
Current ratio
2.36
Quick ratio
1.86
Net debt/EBITDA
0.96
Margins
Efficiency
Dividend
EBITDA margin
-157.6%
Gross margin
50.3%
Net margin
-151.2%
Operating margin
-157.2%
Return on assets
-20%
Return on equity
-25.1%
Return on invested capital
-51.7%
Return on capital employed
-30.6%
Return on sales
-176.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PRE stock price
How has the Prenetics Global Limited stock price performed over time
Intraday
-12.59%
1 week
-15.8%
1 month
31.03%
1 year
16.83%
YTD
20.86%
QTD
78.83%
Financial performance
How have Prenetics Global Limited's revenue and profit performed over time
Revenue
$30.62M
Gross profit
$15.4M
Operating income
-$48.14M
Net income
-$46.3M
Gross margin
50.3%
Net margin
-151.2%
Prenetics Global Limited's gross profit has surged by 74% YoY and by 9% QoQ
The net margin has grown by 48% year-on-year and by 18% since the previous quarter
PRE's revenue is up by 41% YoY and by 20% from the previous quarter
Prenetics Global Limited's operating margin has increased by 34% YoY and by 10% from the previous quarter
Price vs fundamentals
How does PRE's price correlate with its fundamentals
Growth
What is Prenetics Global Limited's growth rate over time
Valuation
What is Prenetics Global Limited stock price valuation
P/E
N/A
P/B
0.5
P/S
2.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.45
PRE's EPS is up by 34% year-on-year and by 2.9% since the previous quarter
The price to book (P/B) is 67% more than the last 4 quarters average of 0.3
The equity has declined by 17% year-on-year and by 4.6% since the previous quarter
PRE's revenue is up by 41% YoY and by 20% from the previous quarter
The P/S is 17% above the last 4 quarters average of 2.4
Efficiency
How efficient is Prenetics Global Limited business performance
PRE's return on sales is up by 39% year-on-year and by 4.7% since the previous quarter
PRE's ROIC is up by 36% YoY but it is down by 27% from the previous quarter
The ROE has grown by 13% YoY but it has contracted by 3.3% from the previous quarter
The return on assets is up by 12% year-on-year but it has declined by 3.1% since the previous quarter
Dividends
What is PRE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PRE.
Financial health
How did Prenetics Global Limited financials performed over time
The quick ratio has surged by 90% since the previous quarter but it has declined by 4.6% year-on-year
Prenetics Global Limited's current ratio has surged by 69% QoQ
The debt is 97% smaller than the equity
Prenetics Global Limited's debt to equity has soared by 200% YoY but it has decreased by 25% from the previous quarter
The debt has surged by 144% year-on-year but it has declined by 11% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.